Evidence map›Paper›PMID 34923901›Full record

Trial reportBioengineered2021

Dynamic changes of intestinal flora in patients with irritable bowel syndrome combined with anxiety and depression after oral administration of enterobacteria capsules.

Qingqing Guo, Hao Lin, Pengcheng Chen, Songlin Tan, Zhiyong Wen, Lijian Lin, Jianquan He, Jianbo Wen, Shiyun Lu

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Bioengineered, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 6 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 6 syntheses or guidelines pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Review
  8. Journal of medical microbiology · 2026
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Qingqing GuoDepartment of Intensive Medicine, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.
Hao LinShengli Clinical Medical College, Fujian Medical University, Fuzhou, Fujian, China.ORCID 0000-0002-6692-8544
Pengcheng ChenDepartment of Health Management, Fujian Provincial Hospital South Branch, Fuzhou, Fujian, China.
Songlin TanDepartment of Gastroenterology, Affiliated Ping Xiang Hospital, Southern Medical University, Pingxiang, Jiangxi, China.
Zhiyong WenDepartment of Gastroenterology, Affiliated Ping Xiang Hospital, Southern Medical University, Pingxiang, Jiangxi, China.
Lijian LinDepartment of Emergency, Fujian Provincial Hospital, Fujian Medical University, Fuzhou, Fujian, China.
Jianquan HeSchool of Medicine, Xiamen University, Xiamen, China.
Jianbo WenThe First School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, China.
Shiyun LuShengli Clinical Medical College, Fujian Medical University, Fuzhou, Fujian, China.
Fujian Medical University · CNJiangxi Pingxiang People's Hospital · CNFujian Provincial Hospital · CNXiamen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study investigated the clinical characteristics and dynamic changes of intestinal bacterial community to evaluate the curative effect of fecal microbiota transplantation (FMT) on irritable bowel syndrome with predominant diarrhea (IBS-D) comorbid with anxiety and depression. Total two treatments were designed in randomize-controlled trial includes oral FMT capsules with 1 week (A1), 8 weeks (A2), and 12 weeks (A3), as well as oral empty capsules with 1 week (B1), 8 weeks (B2), and 12 weeks (B3) as control for comparison. The positive therapeutic effects occurred in FMT colonized patient with IBS-D comorbid psychological disorder, demonstrated at alleviated IBS-D severity (IBS-SSS score from 291.11 reduced to 144.44), altered stool type (from 6 changed to 4), reduced anxiety and depression scores (from 18.33 to 8.39 and from 22.33 to 17.78) after FMT-treated 12 weeks. The FMT therapy improved bacterial alpha diversity and the majority bacterial community predominant by

Indexed as

Gastrointestinal MicrobiomeAdministration, OralAdultAgedAnxietyBacteriaBiodiversityCapsulesDepressionDiarrheaEnterobacteriaceaeFecal Microbiota TransplantationFemaleHumansIrritable Bowel SyndromeMaleCapsulesanxiety and depressionbacterial communityDiarrheal irritable bowel syndromefecal microbiota transplantation

Identifiers

PMID34923901
PMCPMC8810103
OpenAlexW4200280148

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.